Budesonide | Health Canada | Drug Product Database | DPD | PharmaCompass.com

Please Wait

Applying Filters...

Grow Your Pharma Business Digitally

Find Suppliers : API/FDF
- Search Our Integrated Database
Services
Excipients
Drugs in Dev.
News
Blog
Market Place
Login

Budesonide
Canada

PharmaCompass Sponsored Ads

Contact Supplier

Coral Budesonide

Contact Supplier

xyz-pharma-m-2024-10-07

Contact Supplier

PharmaCompass Sponsored Ads

Contact Supplier

Transo-Pharm GmbH works globally to supply Active Pharmaceutical Ingredients adhering to the highest quality & GMP standards.

Contact Supplier

xyz-pharma-m-2024-10-07

Contact Supplier

Budesonide

ACCESS ALL DATA, CHEMISTRY

ACCESS ALL DATA
Browse all information
CHEMISTRY
Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

67 API Suppliers, 24 USDMF, 27 CEP/COS, 7 JDMF, 7 EU WC, 15 KDMF, 34 NDC API, 43 Listed Suppliers, $ API Reference Price

67 API Suppliers
24 USDMF
27 CEP/COS
7 JDMF
7 EU WC
15 KDMF
34 NDC API
43 Listed Suppliers
$ API Reference Price

DEVELOPMENTS

71 Drugs in Development

71 Drugs in Development

INTERMEDIATES

7 API Suppliers

7 API Suppliers

FINISHED DOSAGE FORMULATIONS

611 FDF Dossiers, 54 FDA Orange Book, 429 Europe, 23 Canada, 13 Australia, 39 South Africa, 53 Listed Dossiers

611 FDF Dossiers
54 FDA Orange Book
429 Europe
23 Canada
13 Australia
39 South Africa
53 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

TABLET, EXTENDED RELEASE;ORAL - 9MG, AEROSOL, FOAM;RECTAL - 2MG/ACTUATION, SPRAY, METERED;NASAL - 0.032MG/SPRAY, SUSPENSION;INHALATION - 0.25MG/2ML, SUSPENSION;INHALATION - 0.5MG/2ML, SUSPENSION;INHALATION - 1MG/2ML, CAPSULE, DELAYED RELEASE;ORAL - 6MG, CAPSULE, DELAYED RELEASE;ORAL - 9MG, CAPSULE, DELAYED RELEASE;ORAL - 3MG, AEROSOL, METERED;INHALATION - 0.08MG/INH;0.0045MG/INH, AEROSOL, METERED;INHALATION - 0.16MG/INH;0.0045MG/INH

TABLET, EXTENDED RELEASE;ORAL - 9MG
AEROSOL, FOAM;RECTAL - 2MG/ACTUATION
SPRAY, METERED;NASAL - 0.032MG/SPRAY
SUSPENSION;INHALATION - 0.25MG/2ML
SUSPENSION;INHALATION - 0.5MG/2ML
SUSPENSION;INHALATION - 1MG/2ML
CAPSULE, DELAYED RELEASE;ORAL - 6MG
CAPSULE, DELAYED RELEASE;ORAL - 9MG
CAPSULE, DELAYED RELEASE;ORAL - 3MG
AEROSOL, METERED;INHALATION - 0.08MG/INH;0.0045MG/INH
AEROSOL, METERED;INHALATION - 0.16MG/INH;0.0045MG/INH

RELATED EXCIPIENT COMPANIES

1 Evonik, 1 Rochem International Inc, 5 SPI Pharma, 2 Seqens, 9 DKSH, 1 Jai Radhe Sales, 10 Gangwal Healthcare, 6 Nanjing Well Pharmaceutical, 1 Pfanstiehl, 4 ACG Worldwide, 11 Actylis, 1 Aeon Procare, 1 Alcedo Pharmachem, 5 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 23 BASF, 1 Clariant, 14 Corel Pharma Chem, 4 DFE Pharma, 3 Doshion Polyscience, 2 Finar, 10 Gangwal Chemicals, 9 Ideal Cures Pvt Ltd, 2 Ingredion Pharma Solutions, 31 Kerry, 5 Kima Chemical, 6 Lonza Capsugel, 16 Microlex e.U, 1 Nanjing Bold Chemical, 2 Nomisma Healthcare, 1 Novo Excipients, 1 Pharmatrans-Sanaq, 5 Pluviaendo, 2 Prachin Chemical, 1 Qianhao Chemical (Hebei) Co., Ltd, 2 Qualicaps, 18 Roquette, 14 Seppic, 4 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 10 Sigachi Industries, 4 The Dow Chemical Company, 2 Valens Pharmachem, 2 Vasa Pharmachem, 2 Vertellus

EXCIPIENTS BY APPLICATIONS

67 Coating Systems & Additives, 66 Fillers, Diluents & Binders, 41 Controlled & Modified Release, 33 Thickeners and Stabilizers, 30 Direct Compression, 24 Solubilizers, 20 Film Formers & Plasticizers, 20 Granulation, 19 Lubricants & Glidants, 19 Taste Masking, 18 Topical, 15 Parenteral, 15 Co-Processed Excipients, 11 Disintegrants & Superdisintegrants, 9 Emulsifying Agents, 9 Empty Capsules, 6 Rheology Modifiers, 6 Chewable & Orodispersible Aids, 5 API Stability Enhancers, 5 Coloring Agents, 4 Vegetarian Capsules, 4 Surfactant & Foaming Agents

67 Coating Systems & Additives
66 Fillers, Diluents & Binders
41 Controlled & Modified Release
33 Thickeners and Stabilizers
30 Direct Compression
24 Solubilizers
20 Film Formers & Plasticizers
20 Granulation
19 Lubricants & Glidants
19 Taste Masking
18 Topical
15 Parenteral
15 Co-Processed Excipients
11 Disintegrants & Superdisintegrants
9 Emulsifying Agents
9 Empty Capsules
6 Rheology Modifiers
6 Chewable & Orodispersible Aids
5 API Stability Enhancers
5 Coloring Agents
4 Vegetarian Capsules
4 Surfactant & Foaming Agents

DIGITAL CONTENT

5 DATA COMPILATION #PharmaFlow, 1 STOCK RECAP #PipelineProspector, 129 NEWS #PharmaBuzz

5 DATA COMPILATION #PharmaFlow
1 STOCK RECAP #PipelineProspector
129 NEWS #PharmaBuzz

GLOBAL SALES INFORMATION

5 US Medicaid Prescriptions, 232 Finished Drug Prices, 37 Annual Reports

5 US Medicaid Prescriptions
232 Finished Drug Prices
37 Annual Reports

MARKET PLACE

18 APIs, 17 FDF Dossiers, 1 EXCIPIENTS

18 APIs
17 FDF Dossiers
1 EXCIPIENTS

PATENTS & EXCLUSIVITIES

53 US Patents, 5 US Exclusivities, 2 Health Canada Patents

53 US Patents
5 US Exclusivities
2 Health Canada Patents

REF. STANDARDS & IMPURITIES

2 EDQM, 4 USP, 13 Others

2 EDQM
4 USP
13 Others

ANALYTICAL

3 BioAnalytical Methods

3 BioAnalytical Methods

$ API Ref.Price (USD/KG) : 3,439 Xls

Filters

Reset all filters

Filters

FILTER :

filter Applicant Reset all filters

23 All

01 3TARO PHARMACEUTICALS INC

02 9ASTRAZENECA CANADA INC

03 2AVIR PHARMA INC.

04 1BAUSCH HEALTH, CANADA INC.

05 1FERRING INC

06 1MCNEIL CONSUMER HEALTHCARE DIVISION OF JOHNSON & JOHNSON INC

07 2MYLAN PHARMACEUTICALS ULC

08 2TEVA CANADA LIMITED

09 2TILLOTTS PHARMA GMBH

filter Active Ingredients Reset all filters

23 All

01 23BUDESONIDE

filter Dosage Form Reset all filters

23 All

01 1AEROSOL, METERED DOSE

02 1CAPSULE (SUSTAINED-RELEASE)

03 1ENEMA

04 1FOAM

05 2POWDER

06 3POWDER (METERED DOSE)

07 3SPRAY, METERED DOSE

08 8SUSPENSION

09 1TABLET (DELAYED AND EXTENDED RELEASE)

10 2TABLET (ORALLY DISINTEGRATING)

filter Brand Name Reset all filters

23 All

01 1BREZTRI AEROSPHERE

02 1CORTIMENT

03 1ENTOCORT

04 1ENTOCORT ENEMA

05 2JORVEZA

06 2MYLAN-BUDESONIDE AQ

07 1PULMICORT NEBUAMP 0.125 MG/ML

08 1PULMICORT NEBUAMP 0.25 MG/ML

09 1PULMICORT NEBUAMP 0.5 MG/ML

10 3PULMICORT TURBUHALER

11 1RHINOCORT AQUA

12 1SYMBICORT 100 TURBUHALER

13 1SYMBICORT 200 TURBUHALER

14 3TARO-BUDESONIDE

15 2TEVA-BUDESONIDE

16 1UCERIS

Minakem Budesonide

List of Suppliers

Product Main Page

01

TARO PHARMACEUTICALS INC

2024 ACI Convention

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Contact Supplier

Contact Supplier

Digital Content

Regulatory Info : Prescription

Registration Country : Canada

Brand Name : TARO-BUDESONIDE

Dosage Form : SUSPENSION

Dosage Strength : 0.125MG/ML

Packaging :

Approval Date :

Application Number : 2494264

Regulatory Info : Prescription

Registration Country : Canada

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

02

TARO PHARMACEUTICALS INC

2024 ACI Convention

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Contact Supplier

Contact Supplier

Digital Content

Regulatory Info : Prescription

Registration Country : Canada

Brand Name : TARO-BUDESONIDE

Dosage Form : SUSPENSION

Dosage Strength : 0.25MG/ML

Packaging :

Approval Date :

Application Number : 2494272

Regulatory Info : Prescription

Registration Country : Canada

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

03

TARO PHARMACEUTICALS INC

2024 ACI Convention

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Contact Supplier

Contact Supplier

Digital Content

Regulatory Info : Prescription

Registration Country : Canada

Brand Name : TARO-BUDESONIDE

Dosage Form : SUSPENSION

Dosage Strength : 0.5MG/ML

Packaging :

Approval Date :

Application Number : 2494280

Regulatory Info : Prescription

Registration Country : Canada

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

04

ASTRAZENECA CANADA INC

2024 ACI Convention

Not Confirmed

ASTRAZENECA CANADA INC

2024 ACI Convention

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Regulatory Info : Prescription

Registration Country : Canada

Brand Name : PULMICORT NEBUAMP 0.125 MG/ML

Dosage Form : SUSPENSION

Dosage Strength : 0.125MG/ML

Packaging : 2ML

Approval Date :

Application Number : 2229099

Regulatory Info : Prescription

Registration Country : Canada

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

05

ASTRAZENECA CANADA INC

2024 ACI Convention

Not Confirmed

ASTRAZENECA CANADA INC

2024 ACI Convention

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Regulatory Info : Prescription

Registration Country : Canada

Brand Name : PULMICORT NEBUAMP 0.25 MG/ML

Dosage Form : SUSPENSION

Dosage Strength : 0.25MG/ML

Packaging : 2ML

Approval Date :

Application Number : 1978918

Regulatory Info : Prescription

Registration Country : Canada

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

06

ASTRAZENECA CANADA INC

2024 ACI Convention

Not Confirmed

ASTRAZENECA CANADA INC

2024 ACI Convention

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Regulatory Info : Prescription

Registration Country : Canada

Brand Name : PULMICORT TURBUHALER

Dosage Form : POWDER (METERED DOSE)

Dosage Strength : 400MCG/ACT

Packaging : 200 DOSES

Approval Date :

Application Number : 851760

Regulatory Info : Prescription

Registration Country : Canada

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

07

ASTRAZENECA CANADA INC

2024 ACI Convention

Not Confirmed

ASTRAZENECA CANADA INC

2024 ACI Convention

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Regulatory Info : Prescription

Registration Country : Canada

Brand Name : PULMICORT NEBUAMP 0.5 MG/ML

Dosage Form : SUSPENSION

Dosage Strength : 0.5MG/ML

Packaging : 2ML

Approval Date :

Application Number : 1978926

Regulatory Info : Prescription

Registration Country : Canada

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

08

ASTRAZENECA CANADA INC

2024 ACI Convention

Not Confirmed

ASTRAZENECA CANADA INC

2024 ACI Convention

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Regulatory Info : Prescription

Registration Country : Canada

Brand Name : PULMICORT TURBUHALER

Dosage Form : POWDER (METERED DOSE)

Dosage Strength : 200MCG/ACT

Packaging : 200 DOSES

Approval Date :

Application Number : 851752

Regulatory Info : Prescription

Registration Country : Canada

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

09

TILLOTTS PHARMA GMBH

2024 ACI Convention

Not Confirmed

TILLOTTS PHARMA GMBH

2024 ACI Convention

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Regulatory Info : Prescription

Registration Country : Canada

Brand Name : ENTOCORT

Dosage Form : CAPSULE (SUSTAINED-RELEASE)

Dosage Strength : 3MG

Packaging : 100

Approval Date :

Application Number : 2229293

Regulatory Info : Prescription

Registration Country : Canada

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

10

TILLOTTS PHARMA GMBH

2024 ACI Convention

Not Confirmed

TILLOTTS PHARMA GMBH

2024 ACI Convention

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Regulatory Info : Prescription

Registration Country : Canada

Brand Name : ENTOCORT ENEMA

Dosage Form : ENEMA

Dosage Strength : 2.3MG

Packaging : 7 TABLETS, 7 SOLUTIONS

Approval Date :

Application Number : 2052431

Regulatory Info : Prescription

Registration Country : Canada

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

1
2
3

Contact us
to update this info

Privacy policy
Terms and conditions
Disclaimers
LOOKING FOR A SUPPLIER?